Abstract
Efforts to identify risk factors for chronic diseases have tended to involve observational studies characterised by relatively few disease outcomes. In the absence of individual studies of sufficiently large size, synthesis of available evidence from multiple smaller studies can help enhance statistical power and aid appropriate interpretation. While meta-analyses of published findings can help prioritize research hypotheses, they are inherently limited by the scale of the evidence available for review and by vulnerability to potential reporting biases. By contrast, collaborative analyses of individual participant data from a comprehensive set of relevant epidemiological studies can offer several advantages over moderately sized individual studies or meta-analyses of aggregated data. This review describes those advantages with reference to selected examples.
Abbreviations
- BPC3:
-
Breast and Prostate Cancer Cohort Consortium
- CCGC:
-
CRP CHD Genetics Collaboration
- CHD:
-
Coronary heart disease
- CRP:
-
C-reactive protein
- ENGAGE:
-
European Network of Genomic and Genetic Epidemiology
- EPIC:
-
European Prospective Investigation into Cancer and Nutrition
- ERFC:
-
Emerging Risk Factors Collaboration
- GWAS:
-
Genomewide association study
- HDL:
-
High-density lipoprotein
- IPD:
-
Individual participant data
References
Weinberg AM. Impact of large-scale science on the United States: big science is here to stay, but we have yet to make the hard financial and educational choices it imposes. Science. 1961;134(3473):161–4.
Galison P. The many faces of big science. In: Galison P, Hevly B, editors. Big science: the growth of large-scale research. Stanford: Stanford University Press; 1992. p. 1–17.
Chen Z, Lee L, Chen J, Collins R, Wu F, Guo Y, et al. Cohort profile: the Kadoorie study of chronic disease in China (KSCDC). Int J Epidemiol. 2005;34(6):1243–9.
Elliott P, Peakman TC. The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int J Epidemiol. 2008;37(2):234–44.
Lyman GH, Kuderer NM. The strengths and limitations of meta-analyses based on aggregate data. BMC Med Res Methodol. 2005;5(1):14.
Stewart LA, Tierney JF. To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data. Eval Health Prof. 2002;25(1):76–97.
Seminara D, Khoury MJ, O’Brien TR, Manolio T, Gwinn ML, Little J, et al. The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology. 2007;18(1):1–8.
Clarke R, Shipley M, Lewington S, Youngman L, Collins R, Marmot M, et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol. 1999;150(4):341–53.
The Emerging Risk Factors Collaboration. The emerging risk factors collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol. 2007;22(12):839–69.
The Emerging Risk Factors Collaboration. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA. 2009;302(4):412–23.
Barnathan ES. Has lipoprotein ‘little’ (a) shrunk? JAMA. 1993;270(18):2224–5.
The Emerging Risk Factors Collaboration. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302(18):1993–2000.
Cardis E, Richardson L, Deltour I, Armstrong B, Feychting M, Johansen C, et al. The INTERPHONE study: design, epidemiological methods, and description of the study population. Eur J Epidemiol. 2007;22(9):647–64.
Thompson A, Di Angelantonio E, Sarwar N, Erqou S, Saleheen D, Dullaart RP, et al. Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. JAMA. 2008;299(23):2777–88.
Zintzaras E, Lau J. Trends in meta-analysis of genetic association studies. J Hum Genet. 2008;53(1):1–9.
Hunter DJ, Riboli E, Haiman CA, Albanes D, Altshuler D, Chanock SJ, et al. A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer. 2005;5(12):977–85.
National Cancer Institute Cohort Consortium. http://epi.grants.cancer.gov/Consortia/cohort.html. Accessed 29 Nov 2009.
Setiawan VW, Schumacher FR, Haiman CA, Stram DO, Albanes D, Altshuler D, et al. CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev. 2007;16(11):2237–46.
Canzian F, Kaaks R, Cox DG, Henderson KD, Henderson BE, Berg C, et al. Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). BMC Cancer. 2009;9:257.
European Network for Genetic and Genomic Epidemiology (ENGAGE). http://www.euengage.org. Accessed 29 Nov 2009.
Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey SG. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133–63.
Casas JP, Shah T, Hingorani AD, Danesh J, Pepys MB. C-reactive protein and coronary heart disease: a critical review. J Intern Med. 2008;264(4):295–314.
CRP CHD Genetics Collaboration. Collaborative pooled analysis of data on C-reactive protein gene variants and coronary disease: judging causality by Mendelian randomisation. Eur J Epidemiol. 2008;23(8):531–40.
Hunter DJ. Gene-environment interactions in human diseases. Nat Rev Genet. 2005;6(4):287–98.
Bingham S, Riboli E. Diet and cancer—the European prospective investigation into cancer and nutrition. Nat Rev Cancer. 2004;4(3):206–15.
The EPIC-Heart Secretariat. EPIC-Heart: the cardiovascular component of a prospective study of nutritional, lifestyle and biological factors in 520,000 middle-aged participants from 10 European countries. Eur J Epidemiol. 2007;22(2):129–41.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Thompson, A. Thinking big: large-scale collaborative research in observational epidemiology. Eur J Epidemiol 24, 727–731 (2009). https://doi.org/10.1007/s10654-009-9412-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10654-009-9412-1